New flu pill enters first human safety trial
NCT ID NCT07169318
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-stage study tests whether an experimental oral drug called VNT-101 is safe in healthy adults aged 18 to 59. About 78 participants will receive either the drug or a placebo, with some taking a single dose and others taking multiple doses over several days. The goal is to check for side effects and how the body processes the drug, not yet to treat the flu.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altasciences Inc - Kansas City
RECRUITINGOverland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.